{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:41:51Z","timestamp":1785516111924,"version":"3.56.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.lungcan.2012.09.001","type":"journal-article","created":{"date-parts":[[2012,10,4]],"date-time":"2012-10-04T20:02:18Z","timestamp":1349380938000},"page":"263-269","source":"Crossref","is-referenced-by-count":16,"title":["Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: Baseline results of an observational study (FRAME)"],"prefix":"10.1016","volume":"78","clinical-trial-number":[{"clinical-trial-number":"nct01067794","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Philipp A.","family":"Schnabel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier de Castro","family":"Carpeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Leniewski-Kmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees","family":"Kraaij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Visseren-Grul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Dyachkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa","family":"Taipale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allicia","family":"Girvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Moro-Sibilot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.lungcan.2012.09.001_bib0005","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/annonc\/mdr150","article-title":"Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO consensus Conference in Lung Cancer; Lugano 2010","volume":"22","author":"Felip","year":"2011","journal-title":"Ann Oncol"},{"issue":"36","key":"10.1016\/j.lungcan.2012.09.001_bib0010","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1200\/JCO.2009.23.5622","article-title":"American society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer","volume":"27","author":"Azzoli","year":"2009","journal-title":"J Clin Oncol"},{"issue":"Suppl. 5","key":"10.1016\/j.lungcan.2012.09.001_bib0015","doi-asserted-by":"crossref","first-page":"v103","DOI":"10.1093\/annonc\/mdq207","article-title":"Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Crin?","year":"2010","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.lungcan.2012.09.001_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2004.10.014","article-title":"Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes","volume":"47","author":"Le Chevalier","year":"2005","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2012.09.001_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2007.07.012","volume":"59","author":"Rajeswaran","year":"2008","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2012.09.001_bib0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3816\/CLC.2008.n.030","article-title":"Improving health-related quality of life in non-small-cell lung cancer with current treatment options","volume":"9","author":"Cella","year":"2008","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2012.09.001_bib0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lungcan.2012.09.001_bib0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1634\/theoncologist.2008-0232","article-title":"The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies","volume":"14","author":"Scagliotti","year":"2009","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.lungcan.2012.09.001_bib0045","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3816\/CLC.2004.n.007","article-title":"Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy","volume":"5","author":"Socinski","year":"2004","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2012.09.001_bib0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.lungcan.2003.07.008","article-title":"Taking action to establish direct costs and outcomes of treating advanced non-small cell lung cancer in routine clinical practice","volume":"43","author":"Cullen","year":"2004","journal-title":"Lung Cancer"},{"issue":"36","key":"10.1016\/j.lungcan.2012.09.001_bib0055","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1200\/JCO.2010.28.8126","article-title":"The evolving role of histology in the management of advanced non-small-cell lung cancer","volume":"28","author":"Langer","year":"2010","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.lungcan.2012.09.001_bib0060","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1200\/JCO.2002.02.068","article-title":"Italian Lung Cancer Project. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer","volume":"20","author":"Scagliotti","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2012.09.001_bib0065","series-title":"AJJC Cancer Staging Manual","year":"1997"},{"issue":"3","key":"10.1016\/j.lungcan.2012.09.001_bib0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.lungcan.2011.09.001","article-title":"Cytology-based treatment decision in primary lung cancer: is it accurate enough?","volume":"75","author":"Sakr","year":"2012","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2012.09.001_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2011.10.017","article-title":"The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group","volume":"76","author":"Thunnissen","year":"2012","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2012.09.001_bib0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/PAI.0b013e31802fab75","article-title":"The diagnostic value of TTF-1. CK 5\/6, and p63 immunostaining in classification of lung carcinomas","volume":"15","author":"Kargi","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"5","key":"10.1016\/j.lungcan.2012.09.001_bib0085","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1309\/P5ABR5KQ89RNJTFH","article-title":"p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung","volume":"119","author":"Wu","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.lungcan.2012.09.001_bib0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-0463.2008.00932.x","article-title":"If it's not CK5\/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lung","volume":"116","author":"Downey","year":"2008","journal-title":"APMIS"},{"issue":"5","key":"10.1016\/j.lungcan.2012.09.001_bib0095","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.humpath.2005.12.019","article-title":"Expression of p63, keratin 5\/6, keratin 7, and surfactant-A in non-small cell lung carcinomas","volume":"37","author":"Camilo","year":"2006","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.lungcan.2012.09.001_bib0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2559.2004.01893.x","article-title":"Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade","volume":"45","author":"Jerome Marson","year":"2004","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.lungcan.2012.09.001_bib0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"Suppl. 8","key":"10.1016\/j.lungcan.2012.09.001_bib0110","first-page":"viii132","article-title":"Biomarkers determination in non-small cell lung cancer (NSCLC) across Europe: EPICLIN-lung study","volume":"21","author":"Cruciani","year":"2010","journal-title":"Ann Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500212005259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500212005259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T04:52:53Z","timestamp":1542689573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500212005259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0169500212005259"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2012.09.001","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}